Maximus Appears in 32.0% of AI Answers. Here's Our Five-Step Plan to Improve Its AI Visibility.

Mark HuntleyBy Mark HuntleyFounder and CEO
10 minutes read

Key Takeaways

  • Maximus appeared in 116 of 363 benchmark answers, with 64 recommendations and 49 top-three placements.
  • The main gap is between being mentioned and being endorsed, as competitors receive more affirmative recommendations.
  • The injectable testosterone page is the strongest citation leader and the first priority for page review.
  • Buyer questions cluster around choosing the best TRT company or online clinic, supporting follow-up content briefs.

Answer Capsule

In November 2026, Maximus appeared in 116 of 363 AI answers included in the TRT Clinics benchmark (31.96%). It received 64 recommendations (17.63%), with 49 Top 3 placements and 18 first-place recommendations. A mention means the company appeared in an answer; a recommendation means the answer affirmatively endorsed it.

Our plan compares the company with its competitors, checks conflicting AI claims against reliable sources, and identifies website pages, third-party sources and buyer questions to address. This edition establishes a research baseline. It does not claim a change from earlier editions measured on a different basis. Conflicting AI claims require verification before corrections are proposed.

Current AI visibility

Questions This Section Answers

  • How do Maximus mentions, recommendations and placements compare with its TRT Clinics peers?

Maximus recorded 116 mentions (31.96%) and 64 recommendations (17.63%) across 363 answers included in the benchmark. Top 3 placements numbered 49; first-place recommendations numbered 18. Framing among its mentions was 67 positive, 45 neutral and 4 negative.

Rank

Company

Mentions

Mention rate

Recommendations

Recommendation rate

Top 3

Top 3 rate

#1

#1 rate

1

Hone Health

271

74.66%

146

40.22%

123

33.88%

64

17.63%

2

Defy Medical

113

31.13%

81

22.31%

64

17.63%

12

3.31%

3

Maximus

116

31.96%

64

17.63%

49

13.50%

18

4.96%

4

Marek Health

78

21.49%

39

10.74%

30

8.26%

7

1.93%

5

Henry Meds

86

23.69%

35

9.64%

28

7.71%

6

1.65%

6

Fountain TRT

57

15.70%

25

6.89%

13

3.58%

1

0.28%

7

Renew Vitality

6

1.65%

5

1.38%

5

1.38%

0

0.00%

8

Low T Center

11

3.03%

4

1.10%

2

0.55%

1

0.28%

9

BioTE

7

1.93%

0

0.00%

0

0.00%

0

0.00%

9

Craft Concierge

0

0.00%

0

0.00%

0

0.00%

0

0.00%

Maximus sits in the leading group of clinics named in AI answers, with a mention rate close to the second-ranked clinic and a recommendation rate that trails it. The gap between being named and being endorsed is the practical issue: buyers see the brand, but answers less often put it forward as a choice.

Placement is stronger than raw endorsement, with a meaningful share of recommendations landing in the top three. That suggests the brand is credible when it appears, yet the volume of affirmative recommendations is where competitors pull ahead. A visibility scorecard comparing mention, recommendation and placement side by side would help the client see which lever matters most.

What changed since last month

Questions This Section Answers

  • How did Maximus counts and coverage differ across the available monthly snapshots?

Metric

Nov 2026

Mentions

116 / 363 (31.96%)

Recommendations

64 / 363 (17.63%)

Top 3 recommendations

49 / 363 (13.50%)

#1 recommendations

18 / 363 (4.96%)

Only months with verified results are shown. Monthly sample coverage is listed in Methodology.

This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.

This edition is the first broad baseline, so the figures describe where Maximus stands now rather than a movement from earlier months. Earlier editions used a narrower question set, which means their numbers are not comparable and should not be read as a trend.

The useful takeaway is that future editions built on the same screening scope can be compared against this baseline. Until then, the client should treat this month as a starting reference point and avoid drawing conclusions about direction from the archive.

AI recommendation trend

Observed recommendation rate (%), Nov 2026

  • Maximusno change
    Nov 202617.63%

Separate selected monthly samples. Missing points are unavailable, not zero. Provider/prompt equivalence is unverified; rate movement does not demonstrate causation.

/ Take the next step

Want to Understand Your AI Citation Footprint?

We start every engagement with a full audit of how AI systems reference your brand today.

Measurable, Repeatable Programme

Build a durable foundation of credible citations that compounds over time and continues to influence AI answers as new queries emerge

Citation Architecture Review

Identify which high-authority community sources are and aren't working in your favour across AI platforms.

AI Visibility Audit

Understand exactly how LLMs are referencing your brand today and which sources are shaping those answers.

Step 1. Measure

Questions This Section Answers

  • What should the agency measure and verify first for Maximus?

AI answers contained 0 conflicting claims about Maximus: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No conflicting claims about Maximus were recorded in the captured answers, so there is no immediate fact-checking backlog. That is a clean starting position, but it does not confirm that every statement in circulation is accurate; it means nothing disputed surfaced in this sample.

A scoped fact-review register would still be worthwhile. It would list the claims worth verifying against primary sources, assign an owner to each, and separate confirmed facts from open questions. That gives the client a defensible record before any page or publisher work begins.

Step 2. Make the website consistent

Questions This Section Answers

  • Which recorded claim differences about Maximus should be verified before proposed page edits?

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

No disputed topics were supplied for this part of the analysis, so there is nothing to reconcile yet. The website consistency step should therefore start with verification rather than correction: confirm the entity, dates and sources behind any claim before deciding whether a page needs changing.

Conditional page briefs can be prepared once those checks are done. Each brief would state the approved facts, note where an apparent conflict may simply reflect different dates, and flag anything that needs a primary-source check before an edit is proposed.

Step 3. Align the external narrative

Questions This Section Answers

  • Which cited third-party pages are relevant to fact review for Maximus?

Cited page selected for review

Citation appearances in all captured answers

Answers mentioning the company

Conflicting claims linked to this page

https://innerbody.com/maximus-tribe-reviews

11

11

0

https://bestmedshub.com/guides/maximus-tribe-review-2026/

7

7

0

https://bbb.org/us/ca/santa-monica/profile/vitamins-and-supplements/maximus-tribe-1216-1000044380/complaints

6

6

0

https://leoweekly.com/discover/maximus-tribe-reviews-17137370/

5

5

0

https://nutritionnc.com/glp-1/reviews/maximus-tribe/

5

5

0

https://pparx.org/testosterone/maximus-tribe-review/

5

5

0

These pages were selected because they relate to the company in the captured answers. Their current contents still need checking before any correction request. A page linked to a conflicting claim is not necessarily its cause, and the same answer may contribute to more than one row.

The cited pages selected for review are third-party reviews, a complaints profile and clinic comparison sites. None carried a conflicting claim in this sample, so there is no evidence of publisher error and no basis for demanding a correction.

The sensible work is a source review: check what each page currently says, identify where Maximus is described inaccurately or thinly, and prepare evidence-backed requests only where a genuine gap exists. Publishers control their own content, so requests should be framed as clarifications, with responses tracked separately from confirmed edits.

Step 4. Optimize priority company pages

Questions This Section Answers

  • Which observed Maximus website pages should receive review briefs?

Company website page

Citation appearances in all captured answers

Benchmark answers citing the page

Recommending answers citing the page

https://maximustribe.com/testosterone/injectable-trt

30

30

22

https://maximustribe.com/growth-hormone-peptides/sermorelin-growth-hormone-therapy

3

1

1

https://maximustribe.com/testosterone

2

2

0

https://maximustribe.com/testosterone/Injectable-TRT

2

2

1

https://maximustribe.com/

1

1

0

https://maximustribe.com/at-home-testosterone-test

1

1

0

https://maximustribe.com/lab-tests

1

1

0

https://maximustribe.com/labs

1

1

0

The company's website was cited 50 times across 17 distinct page addresses; the table shows 8 pages selected for review. Zeros in the answer columns mean no matching answers were recorded. A cited page is not automatically a page that accompanied a recommendation.

The injectable testosterone page is by far the most cited company page, appearing across many benchmark answers and a large share of recommending answers. That makes it the natural first candidate for a page brief built on approved facts and the questions buyers actually ask.

Other cited pages, including the growth hormone therapy and lab testing pages, appear far less often. Briefs for those should wait until existing coverage is checked, so the client does not commission new content where a current page already answers the question.

Step 5. Publish around buyer questions

Questions This Section Answers

  • Which observed buyer questions support content briefs for Maximus?

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

What is the best TRT company?

4

3

3

What is the best company to get TRT from?

4

3

3

Which TRT company is best?

5

3

3

What is the best online TRT clinic?

5

2

2

What is the best online TRT company?

4

2

2

What is the best online TRT?

4

2

2

What is the best online testosterone replacement therapy?

2

2

2

What's the best TRT online?

2

2

2

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

The recorded questions cluster around a single theme: which TRT company or online clinic is best. Maximus appears in most of these answers and is recommended in most of the appearances, which suggests the brand is already competitive on the core buying question.

The opportunity is to reinforce that position with content that answers the follow-up questions buyers ask after the shortlist stage. Before proposing new pages, existing coverage should be checked so briefs extend what the site already says rather than duplicate it.

Our 90-day action plan

Questions This Section Answers

  • How should the agency sequence the proposed Maximus work and judge completion?

Period

Deliverable

Completion criterion

Days 1–30

Baseline scorecard, scoped fact-review register and page/source shortlist

Each record has an owner, evidence requirement and review status

Days 31–60

Approved page briefs and justified publisher requests

Separate confirmed edits, no-change decisions, requests and responses

Days 61–90

Buyer-content briefs and a fresh scorecard

Record work completed separately from measured answer outcomes and comparability limits

The first month establishes the baseline scorecard, a scoped fact-review register and a shortlist of pages and sources, each with an owner and review status. This creates the evidence base the later work depends on.

The second month turns that into approved page briefs and justified publisher requests, with confirmed edits, no-change decisions and responses recorded separately. The third month adds buyer-content briefs and a fresh scorecard, with completed work logged apart from measured answer outcomes so the two are never confused.

Methodology

Questions This Section Answers

  • How are Maximus answer metrics and citation populations defined?

This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 363 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.

An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.

The wider citation analysis covers 800 captured answers and 5316 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.

Monthly sample coverage:

Reporting month

Answers included

AI services covered

Services

Nov 2026

363

6

ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity

Earlier editions (July 2026, August 2026, September 2026 and October 2026) used a narrower set of questions. This edition includes all captured answers screened as relevant and establishes a broader baseline. Earlier figures remain in the archive; they are not used to claim a change in performance.

Future editions using the same screening scope can be compared against this baseline.

The answers were collected on dates that have not been verified, and the rates rest on answers that met the benchmark's inclusion rules. A company counts as recommended only when an answer endorses it with positive wording, and top-three and first-place counts sit inside those recommendations rather than adding to them.

Because one answer can name several companies, company counts cannot be summed into distinct answers. Sentiment describes answer wording, not customer satisfaction. Cited pages and disputed claims still need independent checking, and earlier editions are not used to claim a performance change.

Our first three priorities

First, build the baseline scorecard so mention, recommendation and placement are read together, and start the fact-review register even though no conflicting claims surfaced. Second, prepare a brief for the injectable testosterone page, the clear citation leader, using approved facts and buyer questions.

Third, review the selected third-party pages for accuracy before any publisher request, and check existing site coverage before commissioning buyer-question content. Each step should record completed work separately from measured answer outcomes, since none of this work guarantees a change in visibility.

This report supports CiteWorks Studio's examination of how AI search is recommending TRT Clinics. For more detail, you can also read TRT Clinics: AI Visibility Discovery Index.

/ Learn More

Understanding AI search visibility.

AI search experiences create answers by pulling information from many places online and summarizing it into a single response.

What Is AI Citation Intelligence?
AI citation intelligence is the process of measuring where AI platforms source their information and how frequently a brand is mentioned or referenced in AI-generated responses. Because LLMs synthesize across multiple sources, the sites and brands that appear repeatedly tend to influence how a topic or company is framed. This practice focuses on identifying which sources shape AI outputs and tracking brand visibility across different AI systems.
What Is Citation Architecture?
Citation architecture describes the set of sources that consistently inform how AI systems talk about a brand, product, or topic. LLMs draw from websites, articles, forums, and public discussion, and the sources they rely on most often become the backbone of their answers. Building strong citation architecture means ensuring that accurate, credible, high authority sources are the ones most likely to shape the way AI tools summarize and recommend a brand.
What Is Generative Engine Optimization?
Generative engine optimization (GEO) is the practice of improving the chances that AI systems use and cite your brand or content when generating answers. While traditional SEO is centered on ranking pages in search results, GEO focuses on how LLMs retrieve, interpret, and combine information when responding to a question. The objective is to strengthen the content and sources AI systems rely on, so your brand is treated as a trusted reference in AI responses.
What Is AI Share of Voice?
AI share of voice tracks how often a brand appears in AI-generated answers compared with competitors in the same category. It reflects visibility across AI platforms such as ChatGPT, Gemini, Claude, and Perplexity. Monitoring AI share of voice helps organizations see whether AI systems consistently include and recommend their brand for key queries or whether competitor brands are showing up more often.

About The Author

Mark Huntley

Mark Huntley

Founder and CEO

Mark Huntley, J.D. is founder of CiteWorks Studio, a strategic advisory focused on visibility, authority, and recommendation presence in AI-shaped search environments. His work centers on embedding-level GEO, vector optimization, and cosine gap engineering — helping brands align their digital presence with the retrieval systems that increasingly shape discovery, interpretation, and choice.

VIEW ALL CASE STUDIESREQUEST AN AI VISIBILITY AUDIT